rs397515916

Variant summary

Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PS3PP3PP5_Very_Strong

The NM_000256.3(MYBPC3):​c.1624+4A>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000372 in 1,584,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000208041: Published functional studies demonstrate that c.1624+4 A>T results in skipping of exon 17 (Helms et al., 2014" and additional evidence is available in ClinVar. The gene MYBPC3 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000038 ( 0 hom. )

Consequence

MYBPC3
NM_000256.3 splice_region, intron

Scores

2
Splicing: ADA: 0.9685
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:18O:1

Conservation

PhyloP100: 2.40

Publications

9 publications found
Variant links:
Genes affected
MYBPC3 (HGNC:7551): (myosin binding protein C3) MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3 is expressed exclusively in heart muscle and is a key regulator of cardiac contraction. Mutations in this gene are a frequent cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, May 2022]
MYBPC3 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 4
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • left ventricular noncompaction 10
    Inheritance: AD, AR Classification: DEFINITIVE, MODERATE, LIMITED Submitted by: Ambry Genetics
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • atrial fibrillation
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • dilated cardiomyopathy
    Inheritance: AR, AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 13 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000208041: Published functional studies demonstrate that c.1624+4 A>T results in skipping of exon 17 (Helms et al., 2014; Singer et al., 2019); SCV000059070: This variant also been identified in 3/224880 chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant is located in the 5' splice region multiple studies have demonstrated that it causes skipping of exon 17, leading to the introduction of a premature stop codon (Helms 2014, Ito 2017, Springer 2019).; SCV000219148: Studies have shown that this variant results in skipping of exon 17, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 25031304).; SCV004831425: Functional studies with peripheral blood, septal myectomy and transplant specimens have shown that this variant disrupts mRNA splicing, resulting in skipping of exon 17 and introduction of a premature translation stop codon (PMID: 25031304, 30645170).; SCV000917817: "This variant has been reported in the literature in multiple individuals affected with Hypertrophic Cardiomyopathy (Helms_2014). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 16199542, 19574547, 22267749, 23782526, 25031304, 27688314)." Functional studies which show the variant to lead to exon 17 skipping and premature termination (Helms_2014).; SCV000320645: Skipping of exon 17, which is predicted to lead to a frameshift, was detected on analysis of cardiac tissue from an affected carrier, and RNA analysis in blood samples from carriers identified by another group also confirmed skipping of exon 17 (Helms AS et al. Circ Cardiovasc Genet. 2014;7(4):434-43; Singer ES et al. Circ Genom Precis Med. 2019;12(1):e002368).; SCV001344922: Functional RNA studies have shown that this variant causes skipping of exon 17, frameshift and premature truncation, resulting in a truncated or absent protein product (PMID: 25031304, 30645170).; SCV004801386: Functional studies have demonstrated that this variant results in skipping of exon 17 (Helms et al., 2014; Singer et al., 2019).; SCV005362869: Complementary DNA studies in myocardial samples showed that the c.1624+4A>T results in skipping of exon 17 (Helms et al. 2014. PubMed ID: 25031304; Singer et al. 2019. PubMed ID: 30645170).
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
PP5
Variant 11-47342574-T-A is Pathogenic according to our data. Variant chr11-47342574-T-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 42556.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000256.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYBPC3
NM_000256.3
MANE Select
c.1624+4A>T
splice_region intron
N/ANP_000247.2Q14896-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYBPC3
ENST00000545968.6
TSL:5 MANE Select
c.1624+4A>T
splice_region intron
N/AENSP00000442795.1Q14896-1
MYBPC3
ENST00000399249.6
TSL:5
c.1624+4A>T
splice_region intron
N/AENSP00000382193.2A8MXZ9
MYBPC3
ENST00000544791.1
TSL:5
n.1624+4A>T
splice_region intron
N/AENSP00000444259.1F5GZR4

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152102
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000133
AC:
3
AN:
224880
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.0000666
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000197
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000384
AC:
55
AN:
1432076
Hom.:
0
Cov.:
31
AF XY:
0.0000296
AC XY:
21
AN XY:
708990
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33092
American (AMR)
AF:
0.00
AC:
0
AN:
42434
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24226
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39346
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81516
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50590
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5564
European-Non Finnish (NFE)
AF:
0.0000484
AC:
53
AN:
1096168
Other (OTH)
AF:
0.0000338
AC:
2
AN:
59140
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152102
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41426
American (AMR)
AF:
0.00
AC:
0
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
67998
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
5
-
-
not provided (6)
4
-
-
Hypertrophic cardiomyopathy (4)
3
-
-
Hypertrophic cardiomyopathy 4 (3)
2
-
-
Cardiomyopathy (2)
1
-
-
Cardiovascular phenotype (1)
1
-
-
Left ventricular noncompaction 10 (1)
1
-
-
MYBPC3-related disorder (1)
1
-
-
Primary familial hypertrophic cardiomyopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
20
DANN
Benign
0.93
PhyloP100
2.4
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.97
dbscSNV1_RF
Pathogenic
0.79
Splicevardb
3.0
SpliceAI score (max)
0.16
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs397515916; hg19: chr11-47364125; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.